KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Inventory Average (2016 - 2025)

Historic Inventory Average for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Q3 2025 value amounting to $61.7 million.

  • Supernus Pharmaceuticals' Inventory Average fell 659.47% to $61.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.7 million, marking a year-over-year decrease of 659.47%. This contributed to the annual value of $65.9 million for FY2024, which is 2204.69% down from last year.
  • Supernus Pharmaceuticals' Inventory Average amounted to $61.7 million in Q3 2025, which was down 659.47% from $46.7 million recorded in Q2 2025.
  • Supernus Pharmaceuticals' 5-year Inventory Average high stood at $91.3 million for Q1 2023, and its period low was $46.7 million during Q2 2025.
  • For the 5-year period, Supernus Pharmaceuticals' Inventory Average averaged around $71.8 million, with its median value being $73.1 million (2021).
  • In the last 5 years, Supernus Pharmaceuticals' Inventory Average skyrocketed by 9306.31% in 2021 and then tumbled by 3475.99% in 2025.
  • Supernus Pharmaceuticals' Inventory Average (Quarter) stood at $73.1 million in 2021, then grew by 19.57% to $87.4 million in 2022, then dropped by 7.91% to $80.4 million in 2023, then dropped by 26.49% to $59.1 million in 2024, then grew by 4.35% to $61.7 million in 2025.
  • Its Inventory Average stands at $61.7 million for Q3 2025, versus $46.7 million for Q2 2025 and $51.9 million for Q1 2025.